Teneligliptin alert: CDSCO adds bullous pemphigoid to drug safety warning
CDSCO has alerted patients taking teneligliptin about bullous pemphigoid, a rare autoimmune skin condition, and directed drug companies to update…
CDSCO has alerted patients taking teneligliptin about bullous pemphigoid, a rare autoimmune skin condition, and directed drug companies to update…